CYBERDYNE (7779) AI Stock Analysis

• Market Cap: $39.58B
• Dividend Yield: N/A
• Average Volume (3M): 856.30K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.71
• Revenue Growth: 0.71%
• EPS Growth: 60.93%
• Country: JP
• Employees: 227
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Devices
• EPS (TTM): 1.19
• Shares Outstanding: 137,445,820
• 10 Day Avg. Volume: 535,010
• 30 Day Avg. Volume: 856,296
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.77
• Enterprise Value/Revenue: 6.97
• Enterprise Value/Gross Profit: 13.71
• Enterprise Value/Ebitda: -68.10
• 1Y Price Target: $227.14
• Price Target Upside: 22.12% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 51 Neutral
• Price Target: ¥181.00 ▼(-2.69% Downside)

CYBERDYNE's overall stock score is driven by its solid revenue growth and strong equity position, though offset by significant profitability issues and negative cash flows. The technical analysis shows favorable momentum, but valuation remains a concern due to negative earnings.

CYBERDYNE Business Overview & Revenue Model

Company Description

CYBERDYNE Inc. (7779) is a Japanese robotics and technology company specializing in the development of innovative solutions to enhance human capabilities. The company is renowned for its advanced robotic exoskeleton suits, primarily the Hybrid Assistive Limb (HAL), which is designed to aid individuals with physical disabilities. Additionally, CYBERDYNE is involved in the fields of medical and welfare equipment, as well as disaster response and infrastructure maintenance technologies.

How the Company Makes Money

CYBERDYNE generates revenue through the sale and rental of its robotic and assistive products, including the HAL exoskeleton suits, to hospitals, rehabilitation centers, and individuals. The company also earns income from service contracts and maintenance fees associated with these products. Moreover, CYBERDYNE engages in research and development partnerships, government contracts, and collaborations with other organizations, which provide additional financial support. The company may benefit from subsidies and grants aimed at promoting technological innovation in healthcare and robotics.

CYBERDYNE Financial Statement Overview

Summary

CYBERDYNE exhibits strong revenue growth and a robust equity position, indicating long-term stability. However, persistent profitability challenges and negative cash flows suggest operational inefficiencies and a reliance on external financing.

Income Statement

CYBERDYNE's revenue has shown a positive growth trend with an increase from ¥1,792 million in 2020 to ¥4,384 million in 2025. The gross profit margin remains strong, but the company consistently reports negative net income and EBIT, indicating challenges in controlling operating expenses. Despite EBITDA turning positive in 2025, the negative net profit margin and EBIT margin highlight ongoing profitability issues.

Balance Sheet

CYBERDYNE maintains a healthy equity ratio, with stockholders' equity comprising a significant portion of total assets. The debt-to-equity ratio remains low, indicating limited leverage and financial stability. However, the consistent negative net income affects the return on equity, posing growth challenges.

Cash Flow

The company's operating cash flow has been consistently negative, posing liquidity risks. Despite this, CYBERDYNE has improved its free cash flow position in recent years. The free cash flow to net income ratio remains adverse due to negative earnings, and there is substantial reliance on external financing.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	4.38B	4.35B	3.29B	2.15B	1.88B
Gross Profit	2.37B	2.39B	1.79B	1.46B	1.28B
EBITDA	33.00M	-2.00M	-616.00M	116.00M	-278.00M
Net Income	-577.00M	-1.48B	-298.00M	-492.00M	-59.00M
Balance Sheet
Total Assets	48.55B	50.00B	50.19B	49.46B	48.12B
Cash, Cash Equivalents and Short-Term Investments	6.82B	5.16B	17.31B	20.83B	25.71B
Total Debt	434.00M	632.00M	669.00M	575.00M	421.00M
Total Liabilities	8.95B	9.52B	8.20B	6.00B	4.33B
Stockholders Equity	39.58B	40.75B	42.10B	43.42B	43.78B
Cash Flow
Free Cash Flow	-726.00M	-1.07B	-652.00M	-2.34B	-1.85B
Operating Cash Flow	-430.00M	-850.00M	-143.00M	-564.00M	-775.00M
Investing Cash Flow	2.33B	-2.08B	2.17B	-1.79B	-2.79B
Financing Cash Flow	-216.00M	160.00M	14.00M	1.25B	617.00M

CYBERDYNE Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 186.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7779, the sentiment is Positive. The current price of 186 is above the 20-day moving average (MA) of 183.50, above the 50-day MA of 178.76, and above the 200-day MA of 178.01, indicating a bullish trend. The MACD of 1.79 indicates Positive momentum. The RSI at 55.82 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7779.

CYBERDYNE Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6823	78 Outperform	¥33.24B	10.88		2.43%	7.99%	28.81%
6678	74 Outperform	¥16.59B	15.92		3.52%	-8.07%	-38.21%
4549	63 Neutral	¥76.08B	34.67		2.29%	3.80%	6.68%
7600	56 Neutral	¥14.38B	10.23		2.76%	4.84%	-148.94%
7779	51 Neutral	$39.58B	―	-1.44%	―	0.71%	60.93%
7777	51 Neutral	¥25.82B	―	-184.59%	―	51.11%	-606.19%
Sector *	50 Neutral	AU$2.58B	3.16	5.87%	2.68%	36.95%	13.61%

CYBERDYNE Corporate Events

CYBERDYNE Inc. Reports Fiscal Year 2025 Financial Results

CYBERDYNE Inc. reported financial results for the fiscal year ending March 31, 2025, highlighting a slight increase in revenue due to product rentals and medical services, despite a decrease in gross profit. The company recorded financial income from investment securities but also faced extraordinary losses due to valuation losses on shares of subsidiaries and affiliates. Operating losses decreased significantly, and R&D expenses rose due to new product development, impacting the overall financial performance.

The most recent analyst rating on (JP:7779) stock is a Buy with a Yen365.00 price target. To see the full list of analyst forecasts on CYBERDYNE stock, see the JP:7779 Stock Forecast page.

CYBERDYNE Reports Improved Losses Amid Revenue Growth

CYBERDYNE Inc. reported a slight increase in revenue for the fiscal year ending March 31, 2025, with a 0.7% rise to 4,384 million yen. Despite this, the company experienced a loss before tax of 879 million yen, which is an improvement from the previous year’s loss of 1,141 million yen. The company has not announced forecasts for the next fiscal year due to uncertainties in its innovative market. The financial results indicate a challenging environment, but the reduction in losses suggests some operational improvements.

The most recent analyst rating on (JP:7779) stock is a Buy with a Yen365.00 price target. To see the full list of analyst forecasts on CYBERDYNE stock, see the JP:7779 Stock Forecast page.